194 related articles for article (PubMed ID: 34453237)
1. Quantitative assessment of fatty liver using ultrasound attenuation imaging.
Lee DH
J Med Ultrason (2001); 2021 Oct; 48(4):465-470. PubMed ID: 34453237
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
Hwang SM; Cho KY
Eur Radiol; 2023 Nov; 33(11):8353-8365. PubMed ID: 37195431
[TBL] [Abstract][Full Text] [Related]
3. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
Khov N; Sharma A; Riley TR
World J Gastroenterol; 2014 Jun; 20(22):6821-5. PubMed ID: 24944472
[TBL] [Abstract][Full Text] [Related]
4. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
Kuroda H; Abe T; Fujiwara Y; Nagasawa T; Takikawa Y
J Med Ultrason (2001); 2021 Oct; 48(4):471-480. PubMed ID: 34415481
[TBL] [Abstract][Full Text] [Related]
6. Radiologic evaluation of nonalcoholic fatty liver disease.
Lee SS; Park SH
World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging.
Rehman A; Darira J; Hamid K; Ahmed MS; Shazlee MK; Amirali A
Cureus; 2022 Mar; 14(3):e23435. PubMed ID: 35494925
[TBL] [Abstract][Full Text] [Related]
9. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of 2-D Shear-Wave Elastography with Propagation Maps and Attenuation Imaging in Patients with Non-Alcoholic Fatty Liver Disease.
Podrug K; Sporea I; Lupusoru R; Pastrovic F; Mustapic S; Bâldea V; Bozin T; Bokun T; Salkic N; Șirli R; Popescu A; Puljiz Z; Grgurevic I
Ultrasound Med Biol; 2021 Aug; 47(8):2128-2137. PubMed ID: 33985827
[TBL] [Abstract][Full Text] [Related]
12. [Research Progress of Quantitative Ultrasound Assessment of Liver Steatosis in Non-alcoholic Fatty Liver Disease].
Chen J; Zhang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):827-832. PubMed ID: 34728047
[TBL] [Abstract][Full Text] [Related]
13. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.
Lee DH
Clin Mol Hepatol; 2017 Dec; 23(4):290-301. PubMed ID: 28994271
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
Bae JS; Lee DH; Lee JY; Kim H; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK; Choi BI
Eur Radiol; 2019 Dec; 29(12):6499-6507. PubMed ID: 31175413
[TBL] [Abstract][Full Text] [Related]
15. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
16. Application of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005-2023).
Zamanian H; Shalbaf A; Zali MR; Khalaj AR; Dehghan P; Tabesh M; Hatami B; Alizadehsani R; Tan RS; Acharya UR
Comput Methods Programs Biomed; 2024 Feb; 244():107932. PubMed ID: 38008040
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-based techniques for the diagnosis of liver steatosis.
Ferraioli G; Soares Monteiro LB
World J Gastroenterol; 2019 Oct; 25(40):6053-6062. PubMed ID: 31686762
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis.
Lee DH; Cho EJ; Bae JS; Lee JY; Yu SJ; Kim H; Lee KB; Han JK; Choi BI
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):797-805.e7. PubMed ID: 32450363
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.
Tada T; Iijima H; Kobayashi N; Yoshida M; Nishimura T; Kumada T; Kondo R; Yano H; Kage M; Nakano C; Aoki T; Aizawa N; Ikeda N; Takashima T; Yuri Y; Ishii N; Hasegawa K; Takata R; Yoh K; Sakai Y; Nishikawa H; Iwata Y; Enomoto H; Hirota S; Fujimoto J; Nishiguchi S
Ultrasound Med Biol; 2019 Oct; 45(10):2679-2687. PubMed ID: 31277922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
